What's happening with the ResMed share price on Wednesday?

The ResMed share price is facing some quarterly headwinds today.

| More on:
Hand with Australian dollar notes handing the money to another hand symbolising ex-dividend date.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The ResMed Inc (ASX: RMD) share price is edging higher today.

Shares in the S&P/ASX 200 Index (ASX: XJO) healthcare stock closed yesterday trading for $29.30. In morning trade on Wednesday, shares are swapping hands for $29.34, up 0.1%.

For some context, the ASX 200 is up 0.6% at this same time.

Here's what's happening.

What's going on with the ASX 200 healthcare company?

The ResMed share price may be trailing the ASX 200 because the sleep treatment company's stock is trading ex-dividend today.

That means investors who buy the stock today will no longer be eligible for the 4.8 US cents per share unfranked dividend.

That passive income payout will go to investors who held ResMed shares at market close yesterday. Eligible investors can expect to see this hit their bank accounts on 14 March.

The company will report on the Aussie dollar equivalent for ASX investors on Friday, 9 February. (At time of writing AU$1 is worth 65.3 US cents.)

It's common for stocks to face some headwinds on the day they trade ex-dividend. All else being equal, the ResMed share price is now factored in at 4.8 US cents less than it would have been yesterday.

Unlike most ASX 200 stocks, ResMed pays dividends on a quarterly basis.

In the quarter just past, the company paid US$70.7 million in dividends. It also repurchased 335,000 shares for US$50 million as part of ResMed's ongoing capital management.

Overall, it was a strong quarter for the company, with revenue up 12% year on year (11% on a constant currency basis) to US$1.2 billion. And profits were well up, with non-GAAP operating profit leaping 20%.

Commenting on the outlook for the sleep treatment company on the day it reported, CEO Mick Farrell said, "ResMed is well-positioned to lean into leading the expansion and growth of sleep health and breathing health. We are the clear leader in a very large and growing market."

ResMed share price snapshot

The steep falls in August and September see the ResMed share price down 7% over 12 months.

Shares have soared 37% since the lows on 25 September.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended ResMed. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Dividend Investing

Person handing out $50 notes, symbolising ex-dividend date.
Dividend Investing

Where I'd invest $10,000 into ASX dividend shares right now

I think these businesses are a strong buy for passive income.

Read more »

A businessman in a suit wears a medal around his neck and raises a fist in victory surrounded by two other businessmen in suits facing the other direction to him.
Dividend Investing

3.4% dividend yield! I'm buying this ASX stock and holding for decades

There are a few things I look for in an ASX stock when I'm looking for my next investment. One…

Read more »

Two people lazing in deck chairs on a beautiful sandy beach throw their hands up in the air.
Dividend Investing

Suncorp shares tread water as investors digest 2026 dividend timeline

Here’s what income investors need to know.

Read more »

A pink piggybank sits in a pile of autumn leaves.
Bank Shares

4% yield: Is NAB's dividend safe?

An expert says NAB's cherished dividend might be under threat.

Read more »

A woman in a bright yellow jumper looks happily at her yellow piggy bank.
Dividend Investing

Experts say these ASX dividend stocks are cheap buys

Income investors might want to check out these shares for their dividends.

Read more »

Happy young couple saving money in piggy bank.
Dividend Investing

Forget term deposits and buy these ASX dividend shares in 2026

Analysts are tipping these shares as buys for income investors. Let's see what they offer.

Read more »

Close up of worker's hand holding young seedling in soybean field.
REITs

A 5.8% yield and 30% undervalued — time for me to buy this ASX 300 passive income star?

It's not easy to say no to 5.8%.

Read more »

A smiling woman dressed in a raincoat raise her arms as the rain comes down.
Dividend Investing

Top picks: 3 ASX dividend stocks for stress-free passive income

If you're after reliability, check out these income shares.

Read more »